March 28th, 9am-1pm | Hall F4+F5
Join us at the NTK Fair to learn more about the NeuroToolKit (NTK), a collaborative initiative between major players in the neurology field, that aims at advancing neurological diseases research through generation of high-quality biomarker data; also, gain hands-on experience with the NTKApps on the AD Workbench, and you will have the opportunity to try out the NTKApp and receive expert support from one of our on-site facilitators. The NTK Fair Pre-Conference is open to everyone registered for AD/PD!
March 31st; 11:10am - 12:55pm
What more needs to be done to overcome barriers and accelerate delivery of advanced diagnostics and optimal care to people living with AD?
Join our expert faculty for this educational symposium to find out!
March 29th, 7am | On Demand
Watch Chad Logan present the NTKApp, a suite of tools for data harmonization, standardized statistical analysis, meta-analysis, and results sharing among academic and industry researchers using ADDI’s AD Workbench, a secure cloud-based research environment that offers storage and compute to researchers.
March 31st; 14:50 - 15:05 | Hall F4+F5
Effect of age, body mass index and apolipoprotein e genotype on plasma biomarkers of amyloid pathology
March 29th, 14:45 - 15:45 | Hall C
This website is a non-promotional global resource intended to facilitate transparent scientific exchange regarding developments in medical research, diagnostics, and disease management. It is intended for healthcare professionals.
This global website is intended for healthcare professionals outside the UK, US, Canada and Australia. The content on this website may include scientific information about experimental or investigational compounds, indications and services that are not approved or valid in your jurisdiction. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website. Information available on this website does not constitute professional medical advice, and Roche and Genentech accept no responsibility for access to or use of the same.